Probiotic Bifidobacterium species stimulate human SLC26A3 gene function and expression in intestinal epithelial cells

American Journal of Physiology - Cell Physiology

Volumn 307, Issue 12, 2014, Pages C1084-C1092

  Kumar, Anoop ^a,c   Hecht, Cameron ^a   Priyamvada, Shubha ^a   Anbazhagan, Arivarasu N ^a   Alakkam, Anas ^a   Borthakur, Alip ^a   Alrefai, Waddah A ^a,b   Gill, Ravinder K ^a   Dudeja, Pradeep K ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

^c Singhania University Pacheri Bari   (India)

Author keywords

Antidiarrheal; Caco 2; Chloride absorption; Downregulated in adenoma

Indexed keywords

DACTINOMYCIN; MESSENGER RNA; PROBIOTIC AGENT; ANTIPORTER; BICARBONATE; BICARBONATE CHLORIDE ANTIPORTER; CHLORIDE; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEIC ACID SYNTHESIS INHIBITOR; PROTEIN KINASE INHIBITOR; SLC26A3 PROTEIN, HUMAN; SLC26A3 PROTEIN, MOUSE;

ANAEROBIC BACTERIUM; ANIMAL EXPERIMENT; ANION EXCHANGE; ANTIDIARRHEAL ACTIVITY; ARTICLE; BIFIDOBACTERIUM; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM INFANTIS; CACO 2 CELL LINE; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE FUNCTION; HT 29 CELL LINE; HUMAN; IMMUNOFLUORESCENCE; INTESTINE EPITHELIUM CELL; LACTOBACILLUS ACIDOPHILUS; LONG TERM CARE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; RNA ISOLATION; SLC26A3 GENE; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CLASSIFICATION; DRUG EFFECTS; EPITHELIUM CELL; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TIME FACTOR;

BIFIDOBACTERIUM; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM BV. INFANTIS; BIFIDOBACTERIUM SP.; LACTOBACILLUS ACIDOPHILUS; MAMMALIA; MUS;

ANIMALS; ANTIPORTERS; BICARBONATES; BIFIDOBACTERIUM; CACO-2 CELLS; CHLORIDE-BICARBONATE ANTIPORTERS; CHLORIDES; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HT29 CELLS; HUMANS; INTESTINAL MUCOSA; MICE, INBRED C57BL; NUCLEIC ACID SYNTHESIS INHIBITORS; PROBIOTICS; PROMOTER REGIONS, GENETIC; PROTEIN KINASE INHIBITORS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; UP-REGULATION;

EID: 84918827359     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00194.2014     Document Type: Article

References (45)

1. Allen SJ, Wareham K, Wang D, Bradley C, Hutchings H, Harris W, Dhar A, Brown H, Foden A, Gravenor MB, Mack D. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 382: 1249–1257, 2013.
2. Alrefai WA, Wen X, Jiang W, Katz JP, Steinbrecher KA, Cohen MB, Williams IR, Dudeja PK, Wu GD. Molecular cloning and promoter analysis of downregulated in adenoma (DRA). Am J Physiol Gastrointest Liver Physiol 293: G923–G934, 2007.
3. Bermudez-Brito M, Munoz-Quezada S, Gomez-Llorente C, Matencio E, Bernal MJ, Romero F, Gil A. Cell-free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation. PLos One 8: e59370, 2013.
4. Borenshtein D, Schlieper KA, Rickman BH, Chapman JM, Schweinfest CW, Fox JG, Schauer DB. Decreased expression of colonic Slc26a3 and carbonic anhydrase IV as a cause of fatal infectious diarrhea in mice. Infect Immun 77: 3639–3650, 2009.
5. Borthakur A, Gill RK, Tyagi S, Koutsouris A, Alrefai WA, Hecht GA, Ramaswamy K, Dudeja PK. The probiotic Lactobacillus acidophilus stimulates chloride/hydroxyl exchange activity in human intestinal epithelial cells. J Nutr 138: 1355–1359, 2008.
6. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254, 1976.
7. Dudeja PK, Gill RK, Ramaswamy K. Absorption-Secretion and Epithelial Cell Function. Clifton, NJ: Humana, 2003.
8. Farkas K, Yeruva S, Rakonczay Z Jr, Ludolph L, Molnar T, Nagy F, Szepes Z, Schnur A, Wittmann T, Hubricht J, Riederer B, Venglovecz V, Lazar G, Kiraly M, Zsembery A, Varga G, Seidler U, Hegyi P. New therapeutic targets in ulcerative colitis: the importance of ion transporters in the human colon. Inflamm Bowel Dis 17: 884–898, 2010.
9. Fuji T, Ohtsuka Y, Lee T, Kudo T, Shoji H, Sato H, Nagata S, Shimizu T, Yamashiro Y. Bifidobacterium breve enhances transforming growth factor beta 1 signaling by regulating Smad7 expression in preterm infants. J Pediatr Gastroenterol Nutr 43: 83–88, 2006.
10. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, Taylor TD, Itoh K, Kikuchi J, Morita H, Hattori M, Ohno H. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469: 543–547, 2011.
11. Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 7: 503–514, 2010.
12. Gill R, Alrefai W, Ramaswamy K, Dudeja P. Mechanisms and regulation of NaCl absorption in the human intestine. Recent Res Dev Physiol 1: 643–677, 2003.
13. Gill RK, Alrefai WA, Dudeja PK. Intestinal anion absorption. In: Physiology of the Gastrointestinal Tract. II. Neurogastroenterology. New York: Elsevier, 2012, p. 1819–1847.
14. Gill RK, Borthakur A, Hodges K, Turner JR, Clayburgh DR, Saksena S, Zaheer A, Ramaswamy K, Hecht G, Dudeja PK. Mechanism underlying inhibition of intestinal apical Cl/OH exchange following infection with enteropathogenic E. coli. J Clin Invest 117: 428–437, 2007.
15. Groeger D, O’Mahony L, Murphy EF, Bourke JF, Dinan TG, Kiely B, Shanahan F, Quigley EM. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes 4: 325–339, 2013.
16. Guandalini S. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol 45 Suppl: S149–S153, 2011.
17. Guarino A, Lo Vecchio A, Canani RB. Probiotics as prevention and treatment for diarrhea. Curr Opin Gastroenterol 25: 18–23, 2009.
18. Heuvelin E, Lebreton C, Bichara M, Cerf-Bensussan N, Heyman M. A Bifidobacterium probiotic strain and its soluble factors alleviate chloride secretion by human intestinal epithelial cells. J Nutr 140: 7–11, 2010.
19. Hoque KM, Chakraborty S, Sheikh IA, Woodward OM. New advances in the pathophysiology of intestinal ion transport and barrier function in diarrhea and the impact on therapy. Expert Rev Anti Infect Ther 10: 687–699, 2012.
20. Kent AJ, Banks MR. Pharmacological management of diarrhea. Gastroenterol Clin North Am 39: 495–507, 2010.
21. Murata K, Villena J, Tomosada Y, Hara R, Chiba E, Shimazu T, Aso H, Suda Y, Iwabuchi N, Xiao J-Z, Saito T, Kitazawa H. Bifidobacteria upregulate expression of Toll-like receptor negative regulator counteracting entrotoxigenic Escherichia coli mediated inflammation in bovine intestinal epitheliocytes. Open J Vet Med 3: 143–155, 2013.
22. Makela S, Kere J, Holmberg C, Hoglund P. SLC26A3 mutations in congenital chloride diarrhea. Hum Mutat 20: 425–438, 2002.
23. Melvin JE, Park K, Richardson L, Schultheis PJ, Shull GE. Mouse down-regulated in adenoma (DRA) is an intestinal Cl–/HCO3– exchanger and is up-regulated in colon of mice lacking the NHE3 Na–/H– exchanger. J Biol Chem 274: 22855–22861, 1999.
24. Moseley RH, Hoglund P, Wu GD, Silberg DG, Haila S, de la Chapelle A, Holmberg C, Kere J. Downregulated in adenoma gene encodes a chloride transporter defective in congenital chloride diarrhea. Am J Physiol Gastrointest Liver Physiol 276: G185–G192, 1999.
25. Musch MW, Arvans DL, Wu GD, Chang EB. Functional coupling of the downregulated in adenoma Cl–/base exchanger DRA and the apical Na–/H– exchangers NHE2 and NHE3. Am J Physiol Gastrointest Liver Physiol 296: G202–G210, 2009.
26. Ng SC, Hart AL, Kamm MA, Stagg AJ, Knight SC. Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis 15: 300–310, 2009.
27. Ohland CL, Macnaughton WK. Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol Gastrointest Liver Physiol 298: G807–G819, 2010.
28. Preidis GA, Hill C, Guerrant RL, Ramakrishna BS, Tannock GW, Versalovic J. Probiotics, enteric and diarrheal diseases, and global health. Gastroenterology 140: 8–14, 2011.
29. Quigley EM. Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults. Nutr Clin Pract 27: 195–200, 2012.
30. Raheja G, Singh V, Ma K, Boumendjel R, Borthakur A, Gill RK, Saksena S, Alrefai WA, Ramaswamy K, Dudeja PK. Lactobacillus acidophilus stimulates the expression of SLC26A3 via a transcriptional mechanism. Am J Physiol Gastrointest Liver Physiol 298: G395–G401, 2010.
31. Ray D, Alpini G, Glaser S. Probiotic Bifidobacterium species: potential beneficial effects in diarrheal disorders. Focus on “Probiotic Bifidobacterium species stimulate human SLC26A3 gene function and expression in intestinal epithelial cells.” Am J Physiol Cell Physiol (September 10, 2014). doi:10.1152/ajpcell.00300.2014.
32. Resta-Lenert S, Barrett KE. Probiotics and commensals reverse TNF-α- and IFN-γ-induced dysfunction in human intestinal epithelial cells. Gastroenterology 130: 731–746, 2006.
33. Saksena S, Tyagi S, Goyal S, Gill RK, Alrefai WA, Ramaswamy K, Dudeja PK. Stimulation of apical Cl–/HCO3– OH– exchanger, SLC26A3 by neuropeptide Y is lipid raft dependent. Am J Physiol Gastrointest Liver Physiol 299: G1334–G1343, 2010.
34. Sandle GI. Infective and inflammatory diarrhoea: mechanisms and opportunities for novel therapies. Curr Opin Pharmacol 11: 634–639, 2011.
35. Schweinfest CW, Spyropoulos DD, Henderson KW, Kim JH, Chapman JM, Barone S, Worrell RT, Wang Z, Soleimani M. slc26a3 (dra)-deficient mice display chloride-losing diarrhea, enhanced colonic proliferation, and distinct up-regulation of ion transporters in the colon. J Biol Chem 281: 37962–37971, 2006.
36. Scully P, Macsharry J, O’Mahony D, Lyons A, O’Brien F, Murphy S, Shanahan F, O’Mahony L. Bifidobacterium infantis suppression of Peyer’s patch MIP-1α and MIP-1 secretion during Salmonella infection correlates with increased local CD4+CD25+ T cell numbers. Cell Immunol 281: 134–140, 2013.
37. Seidler U, Lenzen H, Cinar A, Tessema T, Bleich A, Riederer B. Molecular mechanisms of disturbed electrolyte transport in intestinal inflammation. Ann NY Acad Sci 1072: 262–275, 2006.
38. Shanahan F. Probiotics in inflammatory bowel disease—therapeutic rationale and role. Adv Drug Deliv Rev 56: 809–818, 2004.
39. Singla A, Dwivedi A, Saksena S, Gill RK, Alrefai WA, Ramaswamy K, Dudeja PK. Mechanisms of lysophosphatidic acid (LPA) mediated stimulation of intestinal apical Cl–/OH– exchange. Am J Physiol Gastrointest Liver Physiol 298: G182–G189, 2010.
40. Singla A, Kumar A, Priyamvada S, Tahniyath M, Saksena S, Gill RK, Alrefai WA, Dudeja PK. LPA stimulates intestinal DRA gene transcription via LPA2 receptor, PI3K/AKT, and c-Fos-dependent pathway. Am J Physiol Gastrointest Liver Physiol 302: G618–G627, 2012.
41. Sleator RD. Probiotics—a viable therapeutic alternative for enteric infections especially in the developing world. Discov Med 10: 119–124, 2010.
42. Trejo FM, De Antoni GL, Pérez PF. Protective effect of Bifidobacteria in an experimental model of Clostridium difficile associated colitis. J Dairy Res 80: 263–269, 2013.
43. Wang Z, Wang T, Petrovic S, Tuo B, Riederer B, Barone S, Lorenz JN, Seidler U, Aronson PS, Soleimani M. Renal and intestinal transport defects in Slc26a6-null mice. Am J Physiol Cell Physiol 288: C957–C965, 2005.
44. Yang H, Jiang W, Furth EE, Wen X, Katz JP, Sellon RK, Silberg DG, Antalis TM, Schweinfest CW, Wu GD. Intestinal inflammation reduces expression of DRA, a transporter responsible for congenital chloride diarrhea. Am J Physiol Gastrointest Liver Physiol 275: G1445–G1453, 1998.
45. Yang SK, Jung Y, Kim H, Hong M, Ye BD, Song K. Association of FCGR2A, JAK2 or HNF4A variants with ulcerative colitis in Koreans. Dig Liver Dis 43: 856–861, 2011.